Zobrazeno 1 - 10
of 188
pro vyhledávání: '"Kari JA"'
Autor:
Kari JA, El Desoky SM
Publikováno v:
Pediatric Health, Medicine and Therapeutics, Vol 2012, Iss default, Pp 19-23 (2012)
Jameela A Kari, Sherif M El DesokyDepartment of Pediatrics and Pediatric Nephrology Unit, King Abdulaziz University, Jeddah, Kingdom of Saudi ArabiaAbstract: We report a case of milk alkali syndrome in a 15-month-old infant who had chronic kidney dis
Externí odkaz:
https://doaj.org/article/4ad1bfdba2f148f3982c16d0c2ca1c47
Autor:
Lopez-Garcia SC, Emma F, Walsh SB, Fila M, Hooman N, Zaniew M, Bertholet-Thomas A, Colussi G, Burgmaier K, Levtchenko E, Sharma J, Singhal J, Soliman NA, Ariceta G, Basu B, Murer L, Tasic V, Tsygin A, Decramer S, Gil-Peña H, Koster-Kamphuis L, La Scola C, Gellermann J, Konrad M, Lilien M, Francisco T, Tramma D, Trnka P, Yüksel S, Caruso MR, Chromek M, Ekinci Z, Gambaro G, Kari JA, König J, Taroni F, Thumfart J, Trepiccione F, Winding L, Wühl E, Ağbaş A, Belkevich A, Vargas-Poussou R, Blanchard A
BACKGROUND: Primary distal renal tubular acidosis (dRTA) is a rare disorder, and we aimed to gather data on treatment and long-term outcome. METHODS: We contacted paediatric and adult nephrologists through European professional organizations. Respond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::9e8ae3e16d74a757313b7057b49aceae
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract We aimed to identify distinct longitudinal trends of LDL-cholesterol (LDL-C) levels and investigate these trajectories’ association with statin treatment. This retrospective cohort study used electronic health records from 8592 type 2 diab
Externí odkaz:
https://doaj.org/article/4c8a021b23184b2b8b329e1270eb3ba9
Autor:
Kari Jalkanen, Emma Aarnio, Piia Lavikainen, Jaana Lindström, Markku Peltonen, Tiina Laatikainen, Janne Martikainen
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Early identification of people at elevated risk of type 2 diabetes (T2D) is an important step in preventing or delaying its onset. Pharmacies can serve as a significant channel to reach these people. This study aimed to assess the
Externí odkaz:
https://doaj.org/article/7fbf777d3885480e83a06f48416aa2b4
Autor:
Janne Martikainen, Aku-Ville Lehtimäki, Kari Jalkanen, Piia Lavikainen, Teemu Paajanen, Heidi Marjonen, Kati Kristiansson, Jaana Lindström, Markus Perola
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Type 2 diabetes (T2D) with increasing prevalence is a significant global public health challenge. Obesity, unhealthy diet, and low physical activity are one of the major determinants of the rise in T2D prevalence. In addition, family history and gene
Externí odkaz:
https://doaj.org/article/161a71b82ba74d25837af6aa1fdbc27b
Autor:
Matthew Glen Robertson, Benjamin Bruce Eidenschink, Eriko Iguchi, Stanislav O. Zakharkin, Christopher J. LaRocca, Ezequiel J. Tolosa, Mark J. Truty, Kari Jacobsen, Martin E. Fernandez-Zapico, Julia Davydova
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss , Pp 659-668 (2021)
Encoding the sodium iodide symporter (NIS) by an adenovirus (Ad) is a promising strategy to facilitate non-invasive imaging and radiotherapy of pancreatic cancer. However, insufficient levels of NIS expression in tumor cells have limited its clinical
Externí odkaz:
https://doaj.org/article/a978dc28a1fd4f84b44bea3c49ac95a1
Autor:
Piia Lavikainen, Emma Aarnio, Kari Jalkanen, Hilkka Tirkkonen, Päivi Rautiainen, Tiina Laatikainen, Janne Martikainen
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background A new special reimbursement scheme (SRS) for non-insulin medications used for treatment of hyperglycaemia in type 2 diabetes (T2D) was implemented in Finland on January 1, 2017. The new SRS affected all community-dwelling Finnish
Externí odkaz:
https://doaj.org/article/ed9c2414c44e459ab84b9b601eb0baf5
Autor:
Piia Lavikainen, Emma Aarnio, Miika Linna, Kari Jalkanen, Hilkka Tirkkonen, Päivi Rautiainen, Tiina Laatikainen, Janne Martikainen
Publikováno v:
PLoS ONE, Vol 17, Iss 6 (2022)
Background Treatments should be customized to patients to improve patients’ health outcomes and maximize the treatment benefits. We aimed to identify meaningful data-driven trajectories of incident type 2 diabetes patients with similarities in glyc
Externí odkaz:
https://doaj.org/article/aa0fe83d257343ed8100db255fdb5cb9
Autor:
Kari Jalkanen, Riia Järvenpää, Tanja Tilles-Tirkkonen, Janne Martikainen, Emma Aarnio, Reija Männikkö, Eeva Rantala, Leila Karhunen, Marjukka Kolehmainen, Marja Harjumaa, Kaisa Poutanen, Miikka Ermes, Pilvikki Absetz, Ursula Schwab, Timo Lakka, Jussi Pihlajamäki, Jaana Lindström
Publikováno v:
JMIR Diabetes, Vol 6, Iss 3, p e21356 (2021)
BackgroundClinical trials have shown that type 2 diabetes (T2D) is preventable through lifestyle interventions targeting high-risk people. Nevertheless, large-scale implementation of risk identification followed by preventive interventions has proven
Externí odkaz:
https://doaj.org/article/3651c98901c94ed8815dec0cd3b9373f
Autor:
Hilchen Thode Sommerschild, Christian Lie Berg, Christian Jonasson, Kari Jansdotter Husabø, Mohammad Nouri Sharikabad
Publikováno v:
Norsk Epidemiologi, Vol 29, Iss 1-2 (2021)
In this article we aim to give researchers and other users of drug utilization data a current overview of the twonationwide Norwegian drug databases located at the Norwegian Institute of Public Health (NIPH), withreference to some historical backgrou
Externí odkaz:
https://doaj.org/article/50f5cbda4ac64a20a95ae51a03cfa679